As a new radioactive tracer of PET/CT, 68GA-labeled PSMA ligand had good sensitivity and specificity in detecting primary prostate cancer, and showed superior diagnostic performance in both pooled as well as subgroup analysis estimates. The gene discussed is FOLH1; the disease is prostate carcinoma.